AUIN

Logo AUIN V1
   

Process for maximizing the production of monoclonal antibodies

Carimbo Unesp
Process for maximizing the production of monoclonal antibodies
Low cost
Process for maximizing the production of monoclonal antibodies
Estimula respostas fisiológicas
Process for maximizing the production of monoclonal antibodies
Stimulant
Human Health
PROBLEM

Many clones produced on the murine hybridoma platform produce interesting monoclonal antibodies, but have slower cell machinery, thus becoming clones of low proliferation index, and their process is not industrially scalable. This new technology presents a process of exposure to LED light of these clones capable of optimizing the synthesis of immunoglobins without significantly altering cell growth, thus bringing about improvements in the production process and significant reduction in their costs since more clones would be available and exploitable.

SOLUTION

The use of this new technology provides the development of new equipment or the improvement of existing equipment for the biopharmaceutical industry and promotes an increase in the production of monoclonal antibodies, thus leading to a reduction in the cost of the final product.


Idea

Laboratory

Prototype

Scheduling

Market
Agency Code
15AUIN005
Patent
BR102015003302-8

Agência Unesp de Inovação

Tel: +55 11 5627.0696

auin@unesp.br

https://auin.unesp.br

Date of deposit
13/02/2015
Inventor(s)

Josy Campanhã Vicentini D. Oliveira

Elenice Deffune

Natalia Mayumi Inada

Marjorie de Assis Golim

Woner Mion

Aparecida V. Gonçalves de Souza

Vanderlei Salvador Bagnato